Skip to main content
Top
Published in: Journal of Gastroenterology 8/2023

Open Access 23-06-2023 | Proctocolectomy | Original Article—Alimentary Tract

Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study

Authors: Katsuyoshi Matsuoka, Hajime Yamazaki, Masakazu Nagahori, Taku Kobayashi, Teppei Omori, Yohei Mikami, Toshimitsu Fujii, Shinichiro Shinzaki, Masayuki Saruta, Minoru Matsuura, Takayuki Yamamoto, Satoshi Motoya, Toshifumi Hibi, Mamoru Watanabe, Jovelle Fernandez, Shunichi Fukuhara, Tadakazu Hisamatsu

Published in: Journal of Gastroenterology | Issue 8/2023

Login to get access

Abstract

Background

The YOu and Ulcerative colitis: Registry and Social network (YOURS) is a large-scale, multicenter, patient-focused registry investigating the effects of lifestyle, psychological factors, and clinical practice patterns on patient-reported outcomes in patients with ulcerative colitis in Japan. In this initial cross-sectional baseline analysis, we comprehensively explored impacts of symptom severity or proctocolectomy on nine patient-reported outcomes.

Methods

Patients receiving tertiary care at medical institutions were consecutively enrolled in the YOURS registry. The patients completed validated questionnaires on lifestyle, psychosocial factors, and disease-related symptoms. Severity of symptoms was classified with self-graded stool frequency and rectal bleeding scores (categories: remission, active disease [mild, moderate, severe]). The effects of symptom severity or proctocolectomy on nine scales for quality of life, fatigue, anxiety/depression, work productivity, and sleep were assessed by comparing standardized mean differences of the patient-reported outcome scores.

Results

Of the 1971 survey responses analyzed, 1346 (68.3%) patients were in remission, 583 (29.6%) had active disease, and 42 (2.1%) had undergone proctocolectomy. A linear relationship between increasing symptom severity and worsening quality of life, fatigue, anxiety, depression, and work productivity was observed. Patients with even mild symptoms had worse scores than patients in remission. Patients who had undergone proctocolectomy also had worse scores than patients in remission.

Conclusions

Ulcerative colitis was associated with reduced mood, quality of life, fatigue, and work productivity even in patients with mild symptoms, suggesting that management of active ulcerative colitis may improve patient-reported outcomes irrespective of disease severity. (UMIN Clinical Trials Registry: UMIN000031995, https://​www.​umin.​ac.​jp/​ctr/​index-j.​htm).
Appendix
Available only for authorised users
Literature
1.
2.
3.
go back to reference da Silva BC, Lyra AC, Rocha R, et al. Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis. World J Gastroenterol. 2014;20:9458–67.PubMedPubMedCentralCrossRef da Silva BC, Lyra AC, Rocha R, et al. Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis. World J Gastroenterol. 2014;20:9458–67.PubMedPubMedCentralCrossRef
4.
go back to reference Ghosh S, Louis E, Beaugerie L, et al. Development of the IBD Disk: a visual self-administered tool for assessing disability in inflammatory bowel diseases. Inflamm Bowel Dis. 2017;23:333–40.PubMedCrossRef Ghosh S, Louis E, Beaugerie L, et al. Development of the IBD Disk: a visual self-administered tool for assessing disability in inflammatory bowel diseases. Inflamm Bowel Dis. 2017;23:333–40.PubMedCrossRef
5.
go back to reference Lönnfors S, Vermeire S, Greco M, et al. IBD and health-related quality of life—discovering the true impact. J Crohns Colitis. 2014;8:1281–6.PubMedCrossRef Lönnfors S, Vermeire S, Greco M, et al. IBD and health-related quality of life—discovering the true impact. J Crohns Colitis. 2014;8:1281–6.PubMedCrossRef
6.
go back to reference Calvet X, Argüelles-Arias F, López-Sanromán A, et al. Patients’ perceptions of the impact of ulcerative colitis on social and professional life: results from the UC-LIFE survey of outpatient clinics in Spain. Patient Prefer Adherence. 2018;12:1815–23.PubMedPubMedCentralCrossRef Calvet X, Argüelles-Arias F, López-Sanromán A, et al. Patients’ perceptions of the impact of ulcerative colitis on social and professional life: results from the UC-LIFE survey of outpatient clinics in Spain. Patient Prefer Adherence. 2018;12:1815–23.PubMedPubMedCentralCrossRef
7.
go back to reference Williet N, Sarter H, Gower-Rousseau C, et al. Patient-reported outcomes in a French nationwide survey of inflammatory bowel disease patients. J Crohns Colitis. 2017;11:165–74.PubMedCrossRef Williet N, Sarter H, Gower-Rousseau C, et al. Patient-reported outcomes in a French nationwide survey of inflammatory bowel disease patients. J Crohns Colitis. 2017;11:165–74.PubMedCrossRef
8.
go back to reference Taft TH, Ballou S, Keefer L. A preliminary evaluation of internalized stigma and stigma resistance in inflammatory bowel disease. J Health Psychol. 2013;18:451–60.PubMedCrossRef Taft TH, Ballou S, Keefer L. A preliminary evaluation of internalized stigma and stigma resistance in inflammatory bowel disease. J Health Psychol. 2013;18:451–60.PubMedCrossRef
9.
go back to reference Armuzzi A, Tarallo M, Lucas J, et al. The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and Europe. BMC Gastroenterol. 2020;20:18.PubMedPubMedCentralCrossRef Armuzzi A, Tarallo M, Lucas J, et al. The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and Europe. BMC Gastroenterol. 2020;20:18.PubMedPubMedCentralCrossRef
10.
go back to reference Jones PD, Kappelman MD, Martin CF, et al. Exercise decreases risk of future active disease in patients with inflammatory bowel disease in remission. Inflamm Bowel Dis. 2015;21:1063–71.PubMedCrossRef Jones PD, Kappelman MD, Martin CF, et al. Exercise decreases risk of future active disease in patients with inflammatory bowel disease in remission. Inflamm Bowel Dis. 2015;21:1063–71.PubMedCrossRef
11.
go back to reference Parekh PJ, Oldfield Iv EC, Challapallisri V, et al. Sleep disorders and inflammatory disease activity: chicken or the egg? Am J Gastroenterol. 2015;110:484–8.PubMedCrossRef Parekh PJ, Oldfield Iv EC, Challapallisri V, et al. Sleep disorders and inflammatory disease activity: chicken or the egg? Am J Gastroenterol. 2015;110:484–8.PubMedCrossRef
12.
go back to reference Tinsley A, Ehrlich OG, Hwang C, et al. Knowledge, attitudes, and beliefs regarding the role of nutrition in IBD among patients and providers. Inflamm Bowel Dis. 2016;22:2474–81.PubMedCrossRef Tinsley A, Ehrlich OG, Hwang C, et al. Knowledge, attitudes, and beliefs regarding the role of nutrition in IBD among patients and providers. Inflamm Bowel Dis. 2016;22:2474–81.PubMedCrossRef
13.
go back to reference Barnes EL, Nestor M, Onyewadume L, et al. High dietary intake of specific fatty acids increases risk of flares in patients with ulcerative colitis in remission during treatment with aminosalicylates. Clin Gastroenterol Hepatol. 2017;15:1390–6 (e1).PubMedPubMedCentralCrossRef Barnes EL, Nestor M, Onyewadume L, et al. High dietary intake of specific fatty acids increases risk of flares in patients with ulcerative colitis in remission during treatment with aminosalicylates. Clin Gastroenterol Hepatol. 2017;15:1390–6 (e1).PubMedPubMedCentralCrossRef
14.
go back to reference Kochar B, Barnes EL, Long MD, et al. Depression is associated with more aggressive inflammatory bowel disease. Am J Gastroenterol. 2018;113:80–5.PubMedCrossRef Kochar B, Barnes EL, Long MD, et al. Depression is associated with more aggressive inflammatory bowel disease. Am J Gastroenterol. 2018;113:80–5.PubMedCrossRef
15.
go back to reference Slonim-Nevo V, Sarid O, Friger M, et al. Effect of social support on psychological distress and disease activity in inflammatory bowel disease patients. Inflamm Bowel Dis. 2018;24:1389–400.PubMedCrossRef Slonim-Nevo V, Sarid O, Friger M, et al. Effect of social support on psychological distress and disease activity in inflammatory bowel disease patients. Inflamm Bowel Dis. 2018;24:1389–400.PubMedCrossRef
16.
go back to reference Yamazaki H, Matsuoka K, Fernandez J, et al. Ulcerative colitis outcomes research in Japan: protocol for an observational prospective cohort study of YOURS (YOu and Ulcerative colitis: registry and social network). BMJ Open. 2019;9: e030134.PubMedPubMedCentralCrossRef Yamazaki H, Matsuoka K, Fernandez J, et al. Ulcerative colitis outcomes research in Japan: protocol for an observational prospective cohort study of YOURS (YOu and Ulcerative colitis: registry and social network). BMJ Open. 2019;9: e030134.PubMedPubMedCentralCrossRef
18.
go back to reference Jairath V, Khanna R, Zou GY, et al. Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials. Aliment Pharmacol Ther. 2015;42:1200–10.PubMedCrossRef Jairath V, Khanna R, Zou GY, et al. Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials. Aliment Pharmacol Ther. 2015;42:1200–10.PubMedCrossRef
19.
go back to reference Lewis JD, Chuai S, Nessel L, et al. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008;14:1660–6.PubMedCrossRef Lewis JD, Chuai S, Nessel L, et al. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008;14:1660–6.PubMedCrossRef
20.
go back to reference Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005;14:798–804.PubMedCrossRef Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005;14:798–804.PubMedCrossRef
21.
22.
go back to reference Moser A, Stuck AE, Silliman RA, et al. The eight-item modified Medical Outcomes Study Social Support Survey: psychometric evaluation showed excellent performance. J Clin Epidemiol. 2012;65:1107–16.PubMedPubMedCentralCrossRef Moser A, Stuck AE, Silliman RA, et al. The eight-item modified Medical Outcomes Study Social Support Survey: psychometric evaluation showed excellent performance. J Clin Epidemiol. 2012;65:1107–16.PubMedPubMedCentralCrossRef
23.
go back to reference Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385–96.PubMedCrossRef Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385–96.PubMedCrossRef
24.
go back to reference Mimura C, Griffiths P. A Japanese version of the Perceived Stress Scale: translation and preliminary test. Int J Nurs Stud. 2004;41:379–85.PubMedCrossRef Mimura C, Griffiths P. A Japanese version of the Perceived Stress Scale: translation and preliminary test. Int J Nurs Stud. 2004;41:379–85.PubMedCrossRef
25.
go back to reference Murase N. Validity and reliability of Japanese version of International Physical Activity Questionnaire. J Health Welfare Stat. 2002;49:1–9. Murase N. Validity and reliability of Japanese version of International Physical Activity Questionnaire. J Health Welfare Stat. 2002;49:1–9.
26.
go back to reference Craig CL, Marshall AL, Sjostrom M, et al. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–95.PubMedCrossRef Craig CL, Marshall AL, Sjostrom M, et al. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–95.PubMedCrossRef
28.
go back to reference Brinkman GL, Coates EO Jr. The effect of bronchitis, smoking, and occupation on ventilation. Am Rev Respir Dis. 1963;87:684–93.PubMed Brinkman GL, Coates EO Jr. The effect of bronchitis, smoking, and occupation on ventilation. Am Rev Respir Dis. 1963;87:684–93.PubMed
29.
go back to reference Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn’s Relapse Prevention Trial. Am J Gastroenterol. 1996;91:1571–8.PubMed Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn’s Relapse Prevention Trial. Am J Gastroenterol. 1996;91:1571–8.PubMed
30.
go back to reference Casellas F, Alcala MJ, Prieto L, et al. Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire. Am J Gastroenterol. 2004;99:457–61.PubMedCrossRef Casellas F, Alcala MJ, Prieto L, et al. Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire. Am J Gastroenterol. 2004;99:457–61.PubMedCrossRef
31.
go back to reference Tinsley A, Macklin EA, Korzenik JR, et al. Validation of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2011;34:1328–36.PubMedCrossRef Tinsley A, Macklin EA, Korzenik JR, et al. Validation of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2011;34:1328–36.PubMedCrossRef
32.
go back to reference Zigmond AS, Snaith RP. The Hospital Anxiety and Depression scale. Acta Psychiatr Scand. 1983;67:361–70.PubMedCrossRef Zigmond AS, Snaith RP. The Hospital Anxiety and Depression scale. Acta Psychiatr Scand. 1983;67:361–70.PubMedCrossRef
33.
34.
go back to reference Yamamoto-Furusho JK, Sarmiento-Aguilar A, García-Alanis M, et al. Hospital Anxiety and Depression Scale (HADS): validation in Mexican patients with inflammatory bowel disease. Gastroenterol Hepatol. 2018;41:477–82.PubMedCrossRef Yamamoto-Furusho JK, Sarmiento-Aguilar A, García-Alanis M, et al. Hospital Anxiety and Depression Scale (HADS): validation in Mexican patients with inflammatory bowel disease. Gastroenterol Hepatol. 2018;41:477–82.PubMedCrossRef
35.
go back to reference Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4:353–65.PubMedCrossRef Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4:353–65.PubMedCrossRef
36.
go back to reference Buysse DJ, Reynolds CF III, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.PubMedCrossRef Buysse DJ, Reynolds CF III, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.PubMedCrossRef
37.
go back to reference Doi Y, Minowa M, Uchiyama M, et al. Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) in psychiatric disordered and control subjects. Psychiatry Res. 2000;97:165–72.PubMedCrossRef Doi Y, Minowa M, Uchiyama M, et al. Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) in psychiatric disordered and control subjects. Psychiatry Res. 2000;97:165–72.PubMedCrossRef
38.
go back to reference Saraiva S, Cortez-Pinto J, Barosa R, et al. Evaluation of fatigue in inflammatory bowel disease - a useful tool in daily practice. Scand J Gastroenterol. 2019;54:465–70.PubMedCrossRef Saraiva S, Cortez-Pinto J, Barosa R, et al. Evaluation of fatigue in inflammatory bowel disease - a useful tool in daily practice. Scand J Gastroenterol. 2019;54:465–70.PubMedCrossRef
39.
go back to reference Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: L. Erlbaum Associates; 1988. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: L. Erlbaum Associates; 1988.
40.
go back to reference Baker DM, Folan AM, Lee MJ, et al. A systematic review and meta-analysis of outcomes after elective surgery for ulcerative colitis. Colorectal Dis. 2021;23:18–33.PubMedCrossRef Baker DM, Folan AM, Lee MJ, et al. A systematic review and meta-analysis of outcomes after elective surgery for ulcerative colitis. Colorectal Dis. 2021;23:18–33.PubMedCrossRef
41.
go back to reference Walter E, Hausberger SC, Gross E, et al. Health-related quality of life, work productivity and costs related to patients with inflammatory bowel disease in Austria. J Med Econ. 2020;23:1061–71.PubMedCrossRef Walter E, Hausberger SC, Gross E, et al. Health-related quality of life, work productivity and costs related to patients with inflammatory bowel disease in Austria. J Med Econ. 2020;23:1061–71.PubMedCrossRef
42.
go back to reference Moon JR, Lee CK, Hong SN, et al. Unmet psychosocial needs of patients with newly diagnosed ulcerative colitis: results from the nationwide prospective cohort study in Korea. Gut Liver. 2020;14:459–67.PubMedCrossRef Moon JR, Lee CK, Hong SN, et al. Unmet psychosocial needs of patients with newly diagnosed ulcerative colitis: results from the nationwide prospective cohort study in Korea. Gut Liver. 2020;14:459–67.PubMedCrossRef
43.
go back to reference Villoria A, Garcia V, Dosal A, et al. Fatigue in out-patients with inflammatory bowel disease: prevalence and predictive factors. PLoS One. 2017;12:e0181435.CrossRef Villoria A, Garcia V, Dosal A, et al. Fatigue in out-patients with inflammatory bowel disease: prevalence and predictive factors. PLoS One. 2017;12:e0181435.CrossRef
44.
go back to reference Farrell D, Artom M, Czuber-Dochan W, et al. Interventions for fatigue in inflammatory bowel disease. Cochrane Database Syst Rev. 2020;4: CD012005.PubMed Farrell D, Artom M, Czuber-Dochan W, et al. Interventions for fatigue in inflammatory bowel disease. Cochrane Database Syst Rev. 2020;4: CD012005.PubMed
45.
go back to reference Peyrin-Biroulet L, Sandborn W, Sands BE, et al. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol. 2015;110:1324–38.PubMedCrossRef Peyrin-Biroulet L, Sandborn W, Sands BE, et al. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol. 2015;110:1324–38.PubMedCrossRef
46.
go back to reference Han SW, Gregory W, Nylander D, et al. The SIBDQ: further validation in ulcerative colitis patients. Am J Gastroenterol. 2000;95:145–51.PubMedCrossRef Han SW, Gregory W, Nylander D, et al. The SIBDQ: further validation in ulcerative colitis patients. Am J Gastroenterol. 2000;95:145–51.PubMedCrossRef
47.
go back to reference Peyrin-Biroulet L, Cieza A, Sandborn WJ, et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut. 2012;61:241–7.PubMedCrossRef Peyrin-Biroulet L, Cieza A, Sandborn WJ, et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut. 2012;61:241–7.PubMedCrossRef
48.
go back to reference Le Berre C, Flamant M, Bouguen G, et al. VALIDation of the IBD-disk instrument for assessing disability in inflammatory bowel diseases in a French cohort: the VALIDate study. J Crohns Colitis. 2020;14:1512–23.PubMedCrossRef Le Berre C, Flamant M, Bouguen G, et al. VALIDation of the IBD-disk instrument for assessing disability in inflammatory bowel diseases in a French cohort: the VALIDate study. J Crohns Colitis. 2020;14:1512–23.PubMedCrossRef
49.
go back to reference Dragasevic S, Sokic-Milutinovic A, Stojkovic Lalosevic M, et al. Correlation of patient-reported outcome (PRO-2) with endoscopic and histological features in ulcerative colitis and Crohn’s disease patients. Gastroenterol Res Pract. 2020;2020:2065383.PubMedPubMedCentralCrossRef Dragasevic S, Sokic-Milutinovic A, Stojkovic Lalosevic M, et al. Correlation of patient-reported outcome (PRO-2) with endoscopic and histological features in ulcerative colitis and Crohn’s disease patients. Gastroenterol Res Pract. 2020;2020:2065383.PubMedPubMedCentralCrossRef
Metadata
Title
Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study
Authors
Katsuyoshi Matsuoka
Hajime Yamazaki
Masakazu Nagahori
Taku Kobayashi
Teppei Omori
Yohei Mikami
Toshimitsu Fujii
Shinichiro Shinzaki
Masayuki Saruta
Minoru Matsuura
Takayuki Yamamoto
Satoshi Motoya
Toshifumi Hibi
Mamoru Watanabe
Jovelle Fernandez
Shunichi Fukuhara
Tadakazu Hisamatsu
Publication date
23-06-2023
Publisher
Springer Nature Singapore
Published in
Journal of Gastroenterology / Issue 8/2023
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-023-02005-7

Other articles of this Issue 8/2023

Journal of Gastroenterology 8/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine